Insulin resistance, a key etiological factor in metabolic syndrome, is closely linked to ectopic lipid accumulation and increased intracellular Ca 2+ concentrations in muscle and liver. However, the mechanism by which dysregulated intracellular Ca 2+ homeostasis causes insulin resistance remains elusive. Here nsulin resistance is a systemic metabolic disorder that manifests as decreased insulin-stimulated glucose transport and metabolism in adipocytes and skeletal muscles and as impaired suppression of hepatic gluconeogenesis (1-3). These functional defects may result from impaired insulin signaling in the peripheral tissues. Although the underlying molecular mechanisms of these signaling defects are not completely understood, the dysregulation of Ca 2+ homeostasis in intracellular organelles such as cytosol, endoplasmic reticulum (ER), and mitochondria has emerged as a key pathophysiological event in insulin resistance, obesity, and type 2 diabetes (3-10). In animal models of obesity and insulin resistance, saturated fatty acids have been shown to inhibit the ER calcium importer, the sarco/ER calcium pump, which subsequently leads to elevated cytoplasmic Ca 2+ levels (7, 9-11). Chronically elevated intracellular Ca 2+ has extreme negative effects on the functions of subcellular organelles such as the ER and mitochondria, leading to impaired metabolic homeostasis (5, 9, 10). In contrast, interventions that block Ca 2+ entry into cells not only improved insulin sensitivity and glucose homeostasis in obese subjects and diabetic patients (12, 13), but also restored autophagy (4, 9) and insulin sensitivity in obese mouse models (14). However, the molecular mechanisms that link intracellular Ca 2+ overload to insulin resistance have not been completely elucidated.
Insulin resistance, a key etiological factor in metabolic syndrome, is closely linked to ectopic lipid accumulation and increased intracellular Ca 2+ concentrations in muscle and liver. However, the mechanism by which dysregulated intracellular Ca 2+ homeostasis causes insulin resistance remains elusive. Here, we show that increased intracellular Ca 2+ acts as a negative regulator of insulin signaling. Chronic intracellular Ca 2+ overload in hepatocytes during obesity and hyperlipidemia attenuates the phosphorylation of protein kinase B (Akt) and its key downstream signaling molecules by inhibiting membrane localization of pleckstrin homology (PH) domains. Pharmacological approaches showed that elevated intracellular Ca 2+ inhibits insulin-stimulated Akt phosphorylation and abrogates membrane localization of various PH domain proteins such as phospholipase Cδ and insulin receptor substrate 1, suggesting a common mechanism inhibiting the membrane targeting of PH domains. PH domain-lipid overlay assays confirmed that Ca 2+ abolishes the binding of various PH domains to phosphoinositides (PIPs) with two adjacent phosphate groups, such as PI(3,4)P 2 , PI(4,5)P 2 , and PI(3,4,5)P 3 
I
nsulin resistance is a systemic metabolic disorder that manifests as decreased insulin-stimulated glucose transport and metabolism in adipocytes and skeletal muscles and as impaired suppression of hepatic gluconeogenesis (1) (2) (3) . These functional defects may result from impaired insulin signaling in the peripheral tissues. Although the underlying molecular mechanisms of these signaling defects are not completely understood, the dysregulation of Ca 2+ homeostasis in intracellular organelles such as cytosol, endoplasmic reticulum (ER), and mitochondria has emerged as a key pathophysiological event in insulin resistance, obesity, and type 2 diabetes (3) (4) (5) (6) (7) (8) (9) (10) . In animal models of obesity and insulin resistance, saturated fatty acids have been shown to inhibit the ER calcium importer, the sarco/ER calcium pump, which subsequently leads to elevated cytoplasmic Ca 2+ levels (7, (9) (10) (11) . Chronically elevated intracellular Ca 2+ has extreme negative effects on the functions of subcellular organelles such as the ER and mitochondria, leading to impaired metabolic homeostasis (5, 9, 10) . In contrast, interventions that block Ca 2+ entry into cells not only improved insulin sensitivity and glucose homeostasis in obese subjects and diabetic patients (12, 13) , but also restored autophagy (4, 9) and insulin sensitivity in obese mouse models (14) . However, the molecular mechanisms that link intracellular Ca 2+ overload to insulin resistance have not been completely elucidated.
Insulin-stimulated phosphoinositide 3-kinase (PI3K) catalyzes the phosphorylation of phosphoinositides (PIPs) at the 3-position to produce PI(3,4)P 2 or PI(3,4,5)P 3 , which recruit a variety of signaling proteins with pleckstrin homology (PH) domains, including phosphoinositide-dependent kinase 1 (PDK1) and protein kinase B (Akt) (1, 15) . In turn, Akt acts as a key merge point of the PI(3,4,5)P 3 -mediated insulin signaling system by phosphorylating the enzyme glycogen synthase kinase 3 beta (GSK3β), the forkhead transcription factors, the 160-kDa substrate of Akt (AS160), and cAMP response element-binding protein (CREB) (1) . The activity of the insulin signaling pathway is transiently attenuated by dephosphorylation of PI(3,4,5)P 3
Significance
Insulin resistance is a metabolic disorder in which target cells fail to respond to physiological levels of circulating insulin, leading to hyperinsulinemia and glucose intolerance. The molecular mechanism underlying insulin resistance is still largely unknown. Here, we found that intracellular Ca 2+ overloading in obesity attenuates insulin-stimulated phosphorylation of protein kinase B and its downstream signaling by preventing membrane localization of various pleckstrin homology (PH) domains. When at high intracellular levels, Ca 2+ binds tightly with phosphoinositides to yield Ca 2+ -phosphoinositides (PIPs), abrogating the membrane targeting of PH domains and disrupting insulin signaling. Thus, we identified a previously unknown physiological function of intracellular Ca 2+ as a critical negative regulator of insulin signaling, especially through the formation of Ca 2+ -PIPs.
via phosphoinositide phosphatases such as PTEN and SHIP2, altering its binding specificity and affinity to PH domains (15) . Thus, the binding of PH domains to PI(3,4,5)P 3 has a critical role in regulating Akt function (16) . Aside from enzymatic dephosphorylation of PI(3,4,5)P 3 by phosphoinositide phosphatases, however, other regulatory mechanisms of the binding of PH domains to PI(3,4,5)P 3 have not been reported.
PH domains are small protein modules that occur in a large variety of ∼250 proteins, including Akt/Rac family serine/threonine kinases, Btk/Itk/Tec subfamily tyrosine kinases, phosphoinositidespecific phospholipase C (PLC), the Rho family of GTPases, insulin receptor substrates (IRSs), and cytoskeletal proteins (17) , suggesting their broad and important roles in cell signaling and regulation. PH domains play essential roles in recruiting proteins to the plasma membrane by binding to their phosphoinositides with a broad range of specificity and affinity. PH domains of Akt, Bruton's tyrosine kinase (BTK), and general receptor for phosphoinositides-1 (GRP1) are known to recognize highly specific PI3K products of PI(3,4)P 2 and PI(3,4,5)P 3 (17) . Mutations disrupting PH domain function that abolish PI(3,4,5)P 3 binding cause severe signaling defects such as X-linked agammaglobulinemia in humans and X-linked immunodeficiency in mice (18, 19) . In contrast, mutations that promote constitutive membrane localization of Akt PH domains at the plasma membrane can cause cancer (20) . These findings imply that membrane targeting of PH domains through PI(3,4,5)P 3 recognition is essential for Akt activity.
In To investigate the molecular mechanisms of insulin resistance, we fed mice a high-fat diet (HFD) or normal chow for 8 wk, then fasted the mice overnight and subsequently refed them with normal chow or a HFD for 4 h. We then analyzed the effects of a HFD on the phosphorylation of key insulin signaling molecules, Akt, and its downstream signaling molecules GSK3β and FOXO3. Interestingly, postprandial phosphorylation of Akt at T308 and S473 and the phosphorylation of GSK3β and FOXO3 were dramatically decreased in mice livers after refeeding with a HFD (Fig. 1A) , suggesting that insulin signaling was impaired in the livers of mice fed a HFD for 8 wk. Based on recent findings that dysregulation of intracellular Ca 2+ plays an important role in insulin resistance (5, 9, 10, 21), we next analyzed in vivo levels of intracellular Ca 2+ in the liver of mice fed a HFD or normal chow diet for 10 wk using adenoviral vectors to express calmodulin-based genetically encoded fluorescent calcium indicators (GCaMP6m) (22) . This method results in robust expression of adenoviral GCaMP6m in the hepatocytes of mice fed a HFD (Fig. 1B) , where we observed that the hepatocytes expressing GCaMP6m were significantly elevated in the livers of HFD-fed mice compared with controls ( Fig. 1B) . Quantification of fluorescent signals showed that the intracellular Ca 2+ level was almost threefold higher in the hepatocytes of HFD-fed mice than in control mice regardless of feeding status (Fig. 1C) , demonstrating that intracellular Ca 2+ was highly elevated in the hepatocytes of HFD-fed mice.
To assess whether impaired insulin signaling in mice fed a HFD is associated with increased intracellular Ca 2+ levels, we treated human HepG2 hepatoma cells for 24 h with palmitic acid, a long-chain saturated fatty acid that causes insulin resistance in animals (23) . Similar to our in vivo findings, palmitic acid treatment markedly attenuated the insulin-stimulated phosphorylation of Akt at T308 and S473 and the phosphorylation of GSK3β and FOXO3 in a dose-dependent manner ( Fig.  1D and SI Appendix, Fig. S1 ), indicating that palmitic acid impairs insulin signaling in vitro. Next, we examined the effects of palmitic acid on intracellular Ca 2+ levels in HepG2 cells using the fluorescent dye Fluo-3 acetoxymethyl (AM). We found that palmitic acid significantly elevated intracellular Ca 2+ levels in the HepG2 cells in a dose-dependent manner (Fig. 1E) , showing that intracellular Ca 2+ levels were almost threefold higher in HepG2 cells treated with palmitic acid (Fig. 1F ). These results indicated that exposure to a HFD elevated palmitic acid levels, leading to increased intracellular Ca 2+ levels, suggesting a mechanism responsible for impaired insulin signaling. To further assess the importance of intracellular Ca 2+ overload, we measured intracellular Ca 2+ concentrations in HepG2 cells with Fura-2 AM after palmitic acid treatment for 24 h. Treatment with high concentrations of palmitic acid significantly elevated the baseline intracellular Ca 2+ concentrations (approximately threefold, SI Appendix, Fig. S2A ). Strikingly, high concentrations of palmitic acid led to irregular patterns of sustained intracellular Ca 2+ overload in HepG2 cells (SI Appendix, Fig. S2B ). Thus, we hypothesized that the attenuation of insulin-stimulated Akt phosphorylation by a HFD is potentially driven by elevated intracellular Ca 2+ levels. To investigate the direct effects of elevated intracellular Ca 2+ on Akt phosphorylation, we evaluated the effects of phorbol myristate acetate (PMA) and ionomycin on Akt phosphorylation, both of which are used to trigger intracellular calcium influx. After pretreating the HepG2 cells with PMA or ionomycin for 30 min to induce sustained intracellular Ca 2+ overload, we examined insulinstimulated phosphorylation of Akt after stimulating with insulin (100 nM) for 15 min. Immunoblotting clearly showed that PMA dramatically inhibited insulin-stimulated phosphorylation of Akt at T308 and S473 and its substrates AS160 and FOXO3 in a dosedependent manner ( Fig. 2A and SI Appendix, Fig. S3 ). Confocal images using the fluorescent dye Fluo-3 AM showed that PMA treatment dramatically increased the levels of intracellular free Ca 2+ , which distribution was distinct from that of mitochondria (SI Appendix, Fig. S4 ). This increase was almost fivefold higher compared with controls, indicating that elevated intracellular Ca 2+ is highly correlated with decreased phosphorylation of Akt and its key downstream signaling proteins ( Fig. 2 B and C) . Consistently, ionomycin also significantly decreased insulin-stimulated phosphorylation of Akt, AS160, and FOXO3 ( Fig. 2D and SI Appendix, Fig. S5 ). Indeed, the levels of intracellular Ca 2+ in HepG2 cells treated with ionomycin were markedly higher than in control cells ( Fig. 2 E and F) , suggesting that decreased phosphorylation of Akt is driven by sustained intracellular Ca 2+ overload. Together, these results indicated that intracellular Ca 2+ overload attenuates insulin signaling in HepG2 cells, as well as other cells such as Chinese hamster ovary-insulin receptor (CHO-IR) cells (SI Appendix, Fig. S6 ).
Consistent with a recent study showing that verapamil, a Ca 2+ channel blocker that inhibits calcium entry into intracellular stores, improves hepatic steatosis in mice fed a HFD (9), we found that pretreatment with verapamil increased the sensitivity of insulinstimulated phosphorylation of Akt at T308 and S473 after 15 min of insulin (10 nM) treatment (SI Appendix, Fig. S7A ). Indeed, treatment with verapamil substantially reversed palmitic acid-induced decreases in Akt phosphorylation at T308 and S473
(SI Appendix, Fig. S7 B and C) , suggesting that a calcium channel blocker might reverse or improve impaired insulin signaling. (25) .
The Akt-PH domain recognizes the highly specific PI3K products of PI(3,4)P 2 and PI(3,4,5)P 3 , which are generated transiently upon activation of almost all surface receptors such as insulin and growth factors (1). We treated CHO-IR cells with or without insulin (100 nM). The localization of Akt-PH mCherry was primarily cytoplasmic in unstimulated cells (Fig. 3A) . After stimulation with insulin, Akt-PH mCherry was preferentially localized to the plasma membrane (Fig. 3A) . In contrast, pretreatment with PMA/ionomycin inhibited insulin-stimulated membrane recruitment of Akt-PH mCherry (Fig. 3A) . Similarly, pretreatment with ionomycin led to the inhibition of insulin-stimulated membrane localization of endogenous Akt in CHO-IR cells (SI Appendix, Fig. S8A ), suggesting that intracellular Ca 2+ overload prevents membrane translocation of Akt, potentially by inhibiting PH domain interactions with PI (3,4)P 2 or PI(3,4,5)P 3 .
Because the PLCδ-PH domain recognizes PI(4,5)P 2 , which is present at 10-to 20-fold higher levels than those of PI3K-dependent products PI(3,4)P 2 and PI(3,4,5)P 3 (17), we monitored the subcellular localization of PLCδ-PH GFP in CHO-IR cells. As shown in Fig. 3C , PLCδ-PH GFP was localized to the plasma membrane when transiently expressed in CHO-IR cells. However, PLCδ-PH GFP was rapidly moved from the plasma membrane to the cytosol after simulation with ionomycin or PMA (Fig. 3C) , which was consistent with a previous study (26) . Interestingly, the inhibitory effects of PMA on membrane localization of PLCδ-PH GFP was completely reversed by subsequent chelation of intracellular Ca 2+ by EDTA (Fig. 3C) , implying that higher intracellular Ca 2+ is a negative regulator for membrane targeting of PH domains. Next, we also monitored the subcellular localization of endogenous IRS1 protein containing a PH domain with broad substrate specificity in CHO-IR cells pretreated with ionomycin before insulin stimulation. Again, pretreatment with PMA/ionomycin completely blocked insulin-stimulated membrane localization of endogenous IRS1 protein (SI Appendix, Fig. S8B ), indicating that intracellular Ca 2+ overload prevents membrane translocation of various PH domains by a common mechanism, potentially inhibiting interactions with PIPs.
Finally, to investigate whether physiological elevation of intracellular Ca 2+ in mice fed a HFD inhibits membrane localization of the Akt-PH domain, we examined the subcellular localization of Akt-PH domains in mice fed normal chow or a HFD using adenovirus-mediated overexpression of Akt-PH mCherry. Adenoviral Akt-PH mCherry was mostly localized to the plasma membrane in the hepatocytes of normal chow-fed mice in response to refeeding (insulin stimulation). Concurrent with the increased intracellular Ca 2+ levels in mice fed a HFD ( Fig. 1 B and C) , however, adenoviral Akt-PH mCherry did not translocate to the plasma membrane in the hepatocytes of HFDfed mice (Fig. 3C ). This provides direct evidence for the inhibition of PH domain localization to the plasma membrane via physiological elevation of intracellular Ca 2+ in HFD-fed mice. Taken together, these results demonstrate that sustained intracellular Ca 2+ overload in mice fed a HFD prevents membrane localization of Akt in vivo by inhibiting membrane localization of the PH domain.
Ca

2+ Inhibits the Binding of PH Domains to PIPs with Two Adjacent
Phosphate Groups. The PH domains of Akt, BTK, and GRP1 recognize highly specific PI3K products PI(3,4)P 2 and PI(3,4,5)P 3 , which are generated transiently upon stimulation of almost all cell surface receptors (17) . Because the activation and phosphorylation of Akt are regulated by direct interactions of PI(3,4)P 2 or PI(3,4,5)P 3 with PH domains (16), we reasoned that PH domains play an important role in Ca
2+
-mediated inhibition of Akt phosphorylation. To address this question, we expressed and purified the PH domain of Akt and examined its binding properties toward various PIPs (Fig. 4A) . Protein-lipid overlay experiments showed selective binding of Akt PH domain to PI(3,4)P 2 and PI(3,4,5)P 3 in the absence of Ca 2+ (Fig. 4B) . However, increasing the Ca 2+ concentration inhibited the binding of Akt PH domain to PI(3,4)P 2 and PI(3,4,5)P 3 , suggesting that high concentrations of intracellular Ca 2+ inhibit electrostatic interactions between PH domains and PIPs.
This result also raises the possibility that high intracellular Ca 2+ concentrations may inhibit the binding of other PH domains to various PIPs. We purified PH domains from phospholipase C-δ1(PLC-δ1), which binds most tightly to PI(4,5)P 2 (27) , and other PH domains from adapter proteins for several members of the tyrosine kinase receptor family, such as IRS1 (25) . Consistent with previous findings (27) , protein-lipid overlay experiments showed that the PLC-δ1 PH domain (PLCδ-PH) bound tightly to PI(4,5)P 2 only in the absence of Ca 2+ (Fig. 4C) . However, increasing the Ca 2+ concentration completely abolished the binding of PLCδ-PH to PI(4,5)P 2 . Interestingly, the IRS1-PH domain bound to all of the PIPs, including PI(3)P, PI(4)P, PI(5)P, PI(3,4)P 2 , PI(4,5)P 2 , PI(3,5)P 2 , and PI(3,4,5)P 3 in the absence of Ca 2+ , suggesting that IRS1 has a broad binding specificity for various PIPs (28) . Consistently, higher Ca 2+ concentrations abolished the binding affinity of the IRS1 PH domain to PIPs, including PI(3,4)P 2 , PI(4,5)P 2 , and PI(3,4,5)P 3 (Fig. 4D) , suggesting that Ca 2+ inhibits the binding of PH domains to PIPs with two adjacent phosphate groups. Thus, these results demonstrate that higher intracellular Ca 2+ prevents the binding of PIPs to the PH domains of Akt, PLC-δ1, and IRS1. -mediated inhibition of PH domain binding to PIPs (29) . The PH domain of Akt anchors the phosphates at the 3, 4, and 5 positions of PI(3,4,5)P 3 through electrostatic interactions with positively charged side chains of K14, K23, R25, and R86 (Fig. 4E) , signifying
To distinguish between these two possibilities, we used isothermal titration calorimetry (ITC), the gold standard for measuring binding affinity, to analyze whether Ca 2+ binds to either the PH domain of Akt or PIPs. We examined the thermodynamics of Ca 2+ binding to the PH domain of Akt at 25°C. ITC analysis showed that Ca 2+ does not bind to the PH domain of Akt (Fig. 4F) , suggesting that Ca 2+ may directly interact with PIPs, including PI(3,4)P 2 and PI(3,4,5)P 3 . For the ITC analysis of Ca 2+ binding to PIPs, we made liposomes composed of di-palmitoyl-sn-glycero-3-phosphocholine (POPC)/PI(3,4)P 2 or PI(3,4,5)P 3 (molar ratio of 80:20) (30) . ITC analysis showed that PI(3,4)P 2 bound two molecules of Ca 2+ with strong affinity (K d1 = 4.6 ± 0.7 μM, K d2 = 6.5 ± 0.4 μM) (Fig. 4G) . Ca 2+ also bound PI(4,5)P 2 liposomes with a very high affinity (K d = 6.7 ± 0.12 μM) (Fig. 4H) . Interestingly, PI(3,4,5)P 3 tightly bound two molecules of Ca 2+ , one with high affinity (K d = 15.1 ± 1.5 nM) and the second with low affinity (K d = 4.6 ± 0.14 μM) (Fig. 4I) . These results indicate that Ca 2+ has a high affinity for PIPs with two adjacent phosphate groups and forms Ca 2+ -PIPs, which are highly compatible with physiological concentrations of elevated intracellular Ca 2+ (24) . Importantly, these results are consistent with a wellknown property of inositol phosphate, which mediates the formation of a bidentate (P-Ca 2+ -P) between Ca 2+ and the two acidic phosphate groups of inositol phosphates (31, 32) . Consistent with this observation, previous computational modeling studies (33) have suggested that Ca 2+ can form Ca
-induced PI(4,5)P 2 clusters through electrostatic interactions. Furthermore, Bilkova et al. (34) showed that Ca 2+ directly interacts with the head group phosphates of PI(4,5)P 2 , which further blocks the interactions of the PLCδ-PH domain to PI(4,5)P 2 . Taken together, we demonstrated that intracellular Ca 2+ overload causes the formation of Ca 2+ -PIPs, which prevent the recognition of PIPs by PH domains, likely due to electrostatic repulsion between positively charged side chains of PH domains and Ca
-PIPs (Fig. 4J ).
Discussion
Dysregulation of intracellular Ca
2+ homeostasis is one of the primary causes of insulin resistance in obesity and type 2 diabetes (5, 9, 10), although the molecular mechanisms that underlie these associations are not completely elucidated. Here, we provide evidence that an increased intracellular Ca 2+ concentration in obesity inhibits the phosphorylation of Akt and its critical downstream signaling events by preventing membrane translocation of PH domains to the plasma membrane (Fig. 5) . Thus, we propose the role of Ca 2+ -PIPs as critical negative regulators of the translocation of PH domain-containing molecules to the plasma membrane.
In addition, acute induction of intracellular Ca 2+ flux triggered by ionomycin and PMA markedly suppressed insulin-stimulated Akt phosphorylation, while Ca 2+ channel blockers increased the sensitivity of insulin-stimulated phosphorylation of Akt at T308 and S473, in accordance with earlier studies (9, 35) -PIPs eventually abrogated the binding of PH domains to the membrane due to electrostatic repulsion. Ca 2+ is one of the most versatile and universal signaling components, and it exerts allosteric regulatory effects on many enzymes and proteins (36) . Intracellular Ca 2+ signaling is initiated by a hormone or other agonist binding to a G proteincoupled receptor (GPCR) and subsequent signaling cascades, including the activation of inositol trisphosphate receptor (IP3R) (37) . At physiological levels, glucagon and catecholamine transiently raises intracellular Ca 2+ levels through the activation of IP3R, whereby the elevated Ca 2+ antagonizes insulin signaling by complexing with Ca 2+ -phosphoinositides and inhibiting the membrane recruitment of proteins containing PH domains to phosphoinositides. However, at the pathological conditions such as obesity or type 2 diabetes (38), activation of GPCRs may lead to sustained elevation of cytosolic Ca 2+ levels in hepatocytes through IP3R (37). Thus, dysregulation of intracellular Ca 2+ homeostasis in obesity may disrupt insulin action and mediate insulin resistance by inhibiting membrane localization and activation of proteins with PH domains through sustained formation of Ca 2+ -phosphoinositides (Fig. 5) . Alternatively, sustained high intracellular Ca 2+ in obesity may also activate several Ca 2+ -responsive proteins, such as CaMK (21) , NFAT transcription factors (39) , and PKCs (40) that contribute to the development of insulin resistance.
Conversely, Akt is frequently hyperactivated in human cancer (41) . Mutations that lead to either constitutive membrane localization of PH domains or disruption of the inhibitory interactions between PH domain and kinase domain promote oncogenesis in vivo (42) , suggesting that the Akt PH domain acts as an inhibitor of kinase activation. Although many gaps remain in our understanding of the inhibitory functions of the PH domain in Akt, our findings suggest that Ca 2+ -PIPs in elevated intracellular Ca 2+ conditions may act as negative regulators that eventually block the dissociation of the inhibitory interactions between the PH domain and the kinase domain in Akt. Interestingly, pretreatment of PMA or ionomycin inhibited both EGF-stimulated membrane localization of endogenous Akt and EGF-stimulated phosphorylation of Akt and its downstream signaling molecules in HaCaT cells (SI Appendix, Fig. S9 ). This suggested that intracellular Ca 2+ overload prevents membrane localization of PH domains by other growth factors. These results may explain why increased intracellular Ca 2+ levels induce apoptosis in multiple cell types, including thymocytes (43), neurons (44) , and various cancer cells (45) . Therefore, drugs that inhibit membrane localization of PH domain in Akt may be effective against many human cancers. Further elucidation of the role of Ca 2+ -PIPs in cell biology and physiology may require additional studies to provide new potential targets for pharmacological interventions for major human diseases, including cancer and diabetes. In conclusion, dysregulation of intracellular Ca 2+ homeostasis may contribute to the pathogenesis of insulin resistance, obesity, and type 2 diabetes by preventing the localization of PH domains to the plasma membrane by coupling Ca 2+ -PIPs.
Materials and Methods
C57BL/6 male mice from Orient Bio, Inc. were studied under protocols approved by the animal ethics committee of Gachon University, Lee Gil Ya Cancer and Diabetes Institute (LCDI-2014-0080). For full details of all these processes, see SI Appendix.
